215 related articles for article (PubMed ID: 22221634)
41. Thoracic staging with
Schaarschmidt BM; Grueneisen J; Metzenmacher M; Gomez B; Gauler T; Roesel C; Heusch P; Ruhlmann V; Umutlu L; Antoch G; Buchbender C
Eur Radiol; 2017 Feb; 27(2):681-688. PubMed ID: 27180186
[TBL] [Abstract][Full Text] [Related]
42. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
[TBL] [Abstract][Full Text] [Related]
43. Positron emission tomography scanning is coming to a hospital near you soon!
Bashir H; Shabo G; Nunan TO
Clin Med (Lond); 2008 Apr; 8(2):134-9. PubMed ID: 18478853
[TBL] [Abstract][Full Text] [Related]
44. [Evaluation of bone scintigraphy and (18)F-FDG PET/CT in bone metastases of lung cancer patients].
Portilla-Quattrociocchi H; Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; de Arcocha Torres M; Medina-Quiroz P; del Castillo R; Rubio-Vassallo A; Carril JM
Rev Esp Med Nucl; 2011; 30(1):2-7. PubMed ID: 21208693
[TBL] [Abstract][Full Text] [Related]
45. Comparison of Diagnostic Accuracy for TNM Stage Among Whole-Body MRI and Coregistered PET/MRI Using 1.5-T and 3-T MRI Systems and Integrated PET/CT for Non-Small Cell Lung Cancer.
Ohno Y; Takeshi Y; Takenaka D; Koyama H; Aoyagi K; Yui M
AJR Am J Roentgenol; 2020 Nov; 215(5):1191-1198. PubMed ID: 32960670
[No Abstract] [Full Text] [Related]
46. PET staging of mediastinal lymph nodes in thoracic oncology.
Broderick SR; Meyers BF
Thorac Surg Clin; 2012 May; 22(2):161-6. PubMed ID: 22520283
[TBL] [Abstract][Full Text] [Related]
47. When is it best to repeat a 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan on patients with non-small cell lung cancer who have received neoadjuvant chemoradiotherapy?
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2007 Oct; 84(4):1092-7. PubMed ID: 17888953
[TBL] [Abstract][Full Text] [Related]
48. Comparison of EUS-guided fine needle aspiration and integrated PET-CT in restaging after treatment for locally advanced non-small cell lung cancer.
Stigt JA; Oostdijk AH; Timmer PR; Shahin GM; Boers JE; Groen HJ
Lung Cancer; 2009 Nov; 66(2):198-204. PubMed ID: 19231024
[TBL] [Abstract][Full Text] [Related]
49. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
[TBL] [Abstract][Full Text] [Related]
50. Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003.
Dinan MA; Curtis LH; Carpenter WR; Biddle AK; Abernethy AP; Patz EF; Schulman KA; Weinberger M
J Clin Oncol; 2012 Aug; 30(22):2725-30. PubMed ID: 22753917
[TBL] [Abstract][Full Text] [Related]
51. Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
Collaud S; Lardinois D; Tischler V; Steinert HC; Stahel R; Weder W
Eur J Cardiothorac Surg; 2012 Mar; 41(3):612-6. PubMed ID: 22219415
[TBL] [Abstract][Full Text] [Related]
52. [Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography/computed tomography (TEP/CT) and CT].
Dellestable P; Granel-Brocard F; Rat AC; Olivier P; Régent D; Schmutz JL
Ann Dermatol Venereol; 2011 May; 138(5):377-83. PubMed ID: 21570561
[TBL] [Abstract][Full Text] [Related]
53. [A proposal for the rational use of the PET in oncology].
Borrego Dorado I; Vázquez Albertino R
Rev Esp Med Nucl; 2002 May; 21(3):163-73. PubMed ID: 12206749
[TBL] [Abstract][Full Text] [Related]
54. Limitations of PET and PET/CT in detecting upper gastrointestinal synchronous cancer in patients with head and neck carcinoma.
Yabuki K; Kubota A; Horiuchi C; Taguchi T; Nishimura G; Inamori M
Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):727-33. PubMed ID: 22722946
[TBL] [Abstract][Full Text] [Related]
55. Interpretation and Prognostic Value of Positron Emission Tomography-Computed Tomography After Induction Chemotherapy With or Without Radiation in IIIA-N2 Non-small Cell Lung Cancer Patients Who Receive Curative Surgery.
Kim SH; Lee JH; Lee GJ; Jeong S; Kwak YK; Kim HK; Cho DG; Park YH; Yu M; Yoon SC
Medicine (Baltimore); 2015 Jun; 94(24):e955. PubMed ID: 26091460
[TBL] [Abstract][Full Text] [Related]
56. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
[TBL] [Abstract][Full Text] [Related]
57. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
[TBL] [Abstract][Full Text] [Related]
58. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
Sánchez Sánchez R; Rodríguez Fernández A; Gómez Río M; Alkurdi Martínez A; Castellón Rubio VE; Ramos Font C; Sánchez-Palencia Ramos A; Delgado Pérez JR; Llamas Elvira JM
Rev Esp Med Nucl; 2011; 30(4):211-6. PubMed ID: 21514978
[TBL] [Abstract][Full Text] [Related]
59. Impact of positron emission tomography with computed tomography for image-guided radiotherapy.
Isnardi V; Thureau S; Vera P
Cancer Radiother; 2020 Aug; 24(5):362-367. PubMed ID: 32284178
[TBL] [Abstract][Full Text] [Related]
60. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
